Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06693804 · ClinicalTrials.gov registry record · NA
Ophthalmoscope and Otoscope Training in Family Medicine Residency
A NA study, sponsored by Milton S. Hershey Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 46
- Enrollment target
NCT06693804: Completed NA study, sponsored by Milton S. Hershey Medical Center.
NCT06693804 is a NA study that has completed, run by Milton S. Hershey Medical Center. The registered enrollment target is 46 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06693804, a NA study, has completed, sponsored by Milton S. Hershey Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 46 participants
- Enrollment target
Study Summary
The purpose of the study is to evaluate the effectiveness of Welch Allyn PanOptic Plus Ophthalmoscope with smartphone adaptor, and assess residents' opinions on acceptability and usability of the device and curriculum vs the conventional non-digital device used in current clinical practice.
Primary Outcome
Survey will measure Resident's confidence. Survey will consist of 10 questions based on a Likert scale where a value of 1=not at all confident and 5=very confident. A score of 10 would indicate no confidence and a score of 50 would indicate complete confidence.
Interventions
- OTHER Digital Otoscope and Ophthalmoscope
- OTHER Conventional otoscope and ophthalmoscope
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 46 participants |
| Start Date | 2025-02-05 |
| Est. Completion | 2025-06-01 |
| Phase | NA |
What the finished NCT06693804 record still lists
NCT06693804 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 46 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 2 interventions - of which Digital Otoscope and Ophthalmoscope is the first listed.
NCT06693804 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06693804 about?
NCT06693804 is a clinical study titled "Ophthalmoscope and Otoscope Training in Family Medicine Residency". The purpose of the study is to evaluate the effectiveness of Welch Allyn PanOptic Plus Ophthalmoscope with smartphone adaptor, and assess residents' opinions on acceptability and usability of the device and curriculum vs the conventional non-digital device used in current clinical practice.
What is the current status of trial NCT06693804?
This trial is currently completed. It is a NA study. The enrollment target is 46 participants. The study started on 2025-02-05. Estimated completion is 2025-06-01.
What interventions are being tested in trial NCT06693804?
The interventions under investigation include: Digital Otoscope and Ophthalmoscope (OTHER), Conventional otoscope and ophthalmoscope (OTHER).
Who is sponsoring clinical trial NCT06693804?
This trial is sponsored by Milton S. Hershey Medical Center, which has 396 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06693804's enrollment target sits among peer trials
46 1402nd of 2000 higher than 590 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01890590 · 46 participants · NA
A Phase II Study of Cyberknife Radiosurgery for Renal Cell Carcinoma
- NCT03191149 · 46 participants · Phase 2
Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change
- NCT03510208 · 46 participants · Phase 1
Panitumumab-IRDye800 in Diagnosing Participants With Malignant Glioma Undergoing Surgery
- NCT04048278 · 46 participants · Early Phase 1
Lidocaine Infusion in Pancreatic Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI